| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 187.67B | 189.19B | 208.35B | 241.39B | 157.74B | 105.94B |
| Gross Profit | 36.51B | 30.24B | 64.06B | 55.10B | 22.86B | 10.18B |
| EBITDA | 31.63B | 27.98B | 43.50B | 59.47B | 32.55B | -6.97B |
| Net Income | 1.52B | 381.00M | 15.24B | -1.36B | 7.57B | -20.73B |
Balance Sheet | ||||||
| Total Assets | 280.46B | 282.23B | 280.29B | 288.12B | 287.27B | 267.65B |
| Cash, Cash Equivalents and Short-Term Investments | 35.05B | 34.52B | 28.59B | 29.77B | 30.96B | 29.53B |
| Total Debt | 74.82B | 71.55B | 63.08B | 55.49B | 69.79B | 81.93B |
| Total Liabilities | 202.81B | 203.91B | 194.80B | 205.13B | 196.83B | 182.09B |
| Stockholders Equity | 58.24B | 59.25B | 70.28B | 67.55B | 75.46B | 71.25B |
Cash Flow | ||||||
| Free Cash Flow | 10.67B | 12.00B | 17.75B | 28.86B | 12.72B | -144.00M |
| Operating Cash Flow | 24.30B | 27.30B | 32.04B | 40.93B | 23.61B | 12.16B |
| Investing Cash Flow | -11.24B | -13.25B | -14.87B | -13.71B | -5.69B | -7.86B |
| Financing Cash Flow | -12.51B | -7.30B | -13.36B | -28.02B | -18.08B | 3.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £154.22B | 14.41 | 8.25% | 4.00% | -9.21% | -2.61% | |
73 Outperform | £1.61B | 10.01 | 17.24% | 10.99% | -2.66% | 0.11% | |
71 Outperform | £1.51B | 9.63 | 12.03% | 5.64% | 159.13% | 143.76% | |
69 Neutral | £65.42B | ― | ― | 5.42% | ― | ― | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
63 Neutral | £3.37B | -8.75 | -11.32% | 8.77% | 123.03% | -330.89% | |
54 Neutral | £2.68B | -30.77 | -4.67% | 14.05% | 63.10% | -161.03% |